Sage Journals: Discover world-class research

Abstract

WuXi AppTec suggests “dynamic entities” require highly specialized analytical approaches

Get full access to this article

View all access options for this article.

References

Liu

Zhang

Zhou

, et al. (2018) Characterization of in vivo Biotransformations of Trastuzumab Emtansine (T-DM1) by High-Resolution Mass Spectrometry. mAbs. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204834/

Han

T. H.

, et al. (2013). CYP3A-mediated drug-drug interaction potential and excretion of brentuximab vedotin, an antibody-drug conjugate, in patients with CD30-positive hematologic malignancies. Clinical Pharmacology & Therapeutics. 94(6); 703–713. https://accp1.onlinelibrary.wiley.com/doi/10.1002/jcph.116

Mapping the Next Phase of Analytical Innovation for ADCs

Abstract

Get full access to this article

References